Physician

Sarah Yue Wang, M.D.

According to 2025 Medicare claims, Sarah Wang, M.D. (NPI: 1841581931) practices hematology/oncology in the Tyler, TX market, with the plurality of this provider's patient population coming from Smith, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75702-7524. Wang is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 602 traditional Medicare patients, billed 146,332 HCPCS/CPT codes, and received $2,802,463 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 830 prescription claims across 184 beneficiaries totaling $1,009,852 in drug costs, led by Revlimid (Lenalidomide). 2021 DME data shows 77 claims. Open Payments data shows 118 records totaling $22,122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,674 to $2,802,463. Similarly, Part D prescription costs have risen steadily, from $2,682 to $1,009,852. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.